Tag: ovarian cancer

1. The overall incidence of ovarian mass malignancy was low. 2. Fine needle aspiration cytology (FNAC) had low sensitivity and ...

  1. A weekly dosing regimen of Paclitaxel versus the standard dosing of Paclitaxel every 3 weeks, both administered with ...

1. In a proof-of-concept study of 35 patients with ovarian or endometrial cancer, the use of uterine cavity lavage successfully ...

1. In a phase III trial of 150 patients with epithelial ovarian cancer, the use of adjuvant hormone therapy was ...

1. In a phase II clinical trial of 20 patients with platinum-resistant ovarian cancer, the use of nivolumab, a monoclonal ...

1. Obese women were more likely to experience wound complications. 2. Obese women were more likely to have ≥2 comorbidities ...

1. In a prospective cohort study of over 800 patients with stage III ovarian cancer, less than 50% of all ...

In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Permissive ...

1. Survival for all stages of ovarian cancer improved significantly from 1975 to 2011 even after accounting for general advances ...

1. In patients with advanced, platinum-resistant ovarian cancer, combination therapy of a tyrosine kinase inhibitor, pazopanib, with paclitaxel significantly increased ...